What does it mean if hepatitis antibodies are detected on a Sexually Transmitted Infection (STI) screen?

Hepatitis Antibodies Detected on STI Screen: Interpretation and Next Steps

When hepatitis antibodies are detected on an STI screen, this indicates either past exposure, current infection, or immunity from vaccination—the specific interpretation depends entirely on which antibody type was detected and requires immediate follow-up testing to determine your infection status and guide management.

Understanding What Was Detected

The term "hepatitis antibodies" is non-specific and requires clarification of which hepatitis virus and which specific antibody was found:

Hepatitis B Antibodies

Total anti-HBc (Hepatitis B core antibody):

• This is the most commonly detected marker on STI screens and indicates past or present HBV infection 1, 2
• Total anti-HBc persists indefinitely after HBV exposure and does NOT distinguish between acute, chronic, or resolved infection 1, 2
• You must obtain additional testing immediately: HBsAg (surface antigen), anti-HBs (surface antibody), and IgM anti-HBc to determine your current status 1, 2

Anti-HBs (Hepatitis B surface antibody):

• This indicates immunity—either from successful vaccination or recovery from past infection 3
• When anti-HBs is positive alone (without anti-HBc), this confirms vaccination immunity without prior natural infection 3
• When anti-HBs is positive WITH anti-HBc positive (and HBsAg negative), this indicates recovery from past natural infection with resulting immunity 3

Hepatitis A Antibodies

Total anti-HAV:

• A positive total anti-HAV indicates immunity to hepatitis A but does not differentiate current from previous infection 4
• Can also be positive after hepatitis A vaccination 4

IgM anti-HAV:

• The presence of IgM antibody to HAV is diagnostic of acute HAV infection 4
• This requires supportive care and contact tracing 4

Required Follow-Up Testing Algorithm

If total anti-HBc was detected (most common scenario):

1. Immediately order: HBsAg, anti-HBs, IgM anti-HBc 1, 2

2. Interpret based on the pattern:

   • HBsAg positive + IgM anti-HBc positive = Acute HBV infection 1, 2
   • HBsAg positive + IgM anti-HBc negative = Chronic HBV infection 1, 2
   • HBsAg negative + anti-HBs positive = Resolved infection with immunity 1, 2
   • HBsAg negative + anti-HBs negative = Isolated anti-HBc (may represent resolved infection with waning anti-HBs, false-positive, window period, or occult infection) 2

3. If HBsAg is positive (chronic or acute infection):

   • Measure HBV DNA level, ALT/AST, HBeAg/anti-HBe 1, 2
   • Refer to hepatology or physician experienced in chronic liver disease management 4, 2
   • Test for coinfections: HAV serology, HCV antibody, HIV 2
   • Screen and vaccinate all household and sexual contacts 2

Clinical Significance in STI Context

Hepatitis B is a sexually transmitted infection with high prevalence among certain populations:

• Sexually active persons with multiple partners, MSM, and those with other STDs have significantly elevated HBV risk 5, 6, 7
• The prevalence of HBV markers is 1.65 to 6.76 times higher among persons with current or past STIs compared to those without 7
• All persons evaluated or treated for an STD should receive hepatitis B vaccination unless already vaccinated 4

Hepatitis A transmission in sexual contexts:

• HAV transmission during sexual activity results from fecal-oral contact 4
• Condoms do NOT prevent HAV transmission 4
• MSM, illegal drug users, and persons with chronic liver disease should receive hepatitis A vaccination 4

Critical Management Steps

For confirmed current HBV infection (HBsAg positive):

• Sexual contacts should receive HBIG and begin hepatitis B vaccine series within 14 days after most recent sexual contact 5
• Counsel on transmission prevention: avoid sharing razors/toothbrushes, cover open wounds, clean blood spills with bleach 2
• Avoid heavy alcohol use as it accelerates progression to cirrhosis and hepatocellular carcinoma 2

For resolved infection (anti-HBc positive, HBsAg negative):

• Assess reactivation risk before any immunosuppression (chemotherapy, biologics, high-dose steroids) 2
• Reactivation risk ranges from 3-45% depending on regimen, with highest risk from anti-CD20/CD52 monoclonal antibodies 2
• Consider antiviral prophylaxis if HBV DNA becomes detectable 2

Common Pitfalls to Avoid

• Do not assume "antibodies" means immunity—anti-HBc indicates exposure, NOT protection 1, 2
• Do not delay additional testing—isolated serologic markers cannot determine infection status 1, 2
• Do not restrict IgM anti-HBc testing to symptomatic patients only—false-positives can occur in asymptomatic persons, so only test those with clinical hepatitis or epidemiologic exposure 1
• Do not forget to vaccinate seronegative contacts immediately while awaiting their test results 2
• Do not overlook screening for other STIs—test for syphilis, gonorrhea, chlamydia, HIV, and HCV in all patients with detected hepatitis markers 2